Analysed FIBROBIOLOGICS INC (FBLG:NASDAQ) News Sources
FibroBiologics advances diabetic ulcer trial with new drug shipment to Australia
27-08-2026
proactiveinvestors.com
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
27-08-2026
yahoo.com
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
01-09-2026
yahoo.com
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
08-09-2026
yahoo.com
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
17-09-2026
yahoo.com
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
29-09-2026
yahoo.com
EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
07-10-2026
yahoo.com
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
07-10-2026
yahoo.com
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
14-10-2026
yahoo.com
What is the current price of FIBROBIOLOGICS INC (FBLG:NASDAQ)?
The current price of FIBROBIOLOGICS INC (FBLG:NASDAQ) is $0.9362.
FIBROBIOLOGICS INC (FBLG:NASDAQ) absolute price change since previous trading day?
The absolute price change of FIBROBIOLOGICS INC (FBLG:NASDAQ) since the previous trading day is $-0.0037.
FIBROBIOLOGICS INC (FBLG:NASDAQ) percentage price change since previous trading day?
The percentage price change of FIBROBIOLOGICS INC (FBLG:NASDAQ) since the previous trading day is -0.3937%.
What is the most recent average sentiment score for FIBROBIOLOGICS INC (FBLG:NASDAQ)?
The most recent average sentiment score for FIBROBIOLOGICS INC (FBLG:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for FIBROBIOLOGICS INC (FBLG:NASDAQ)?
The most recent sentiment for FIBROBIOLOGICS INC (FBLG:NASDAQ) is .
SEC-8K** Filing Available For FIBROBIOLOGICS INC (FBLG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.